Covered recipient · General Payments record
JEANINE NICOLE HUNDRIESER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,337.08
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $915.41 | 45 |
| Education | $190.40 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $153.10 | 4 |
| Genentech USA, Inc. | $131.18 | 6 |
| Daiichi Sankyo Inc. | $101.87 | 5 |
| AVEO Pharmaceuticals, Inc. | $91.40 | 1 |
| GENZYME CORPORATION | $61.79 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.91 | 3 |
| Blueprint Medicines Corporation | $46.37 | 2 |
| Sumitomo Pharma America, Inc. | $44.16 | 2 |
| PFIZER INC. | $41.43 | 2 |
| TerSera Therapeutics LLC | $37.83 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.52 | 2 |
| Karyopharm Therapeutics Inc. | $32.07 | 1 |
| ABBVIE INC. | $30.12 | 1 |
| Rigel Pharmaceuticals, Inc. | $28.24 | 2 |
| EISAI INC. | $26.60 | 1 |
| Genmab U.S., Inc. | $22.23 | 1 |
| EMD Serono, Inc. | $21.60 | 1 |
| Gilead Sciences, Inc. | $20.46 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.35 | 1 |
| Incyte Corporation | $19.93 | 1 |
| Acrotech Biopharma Inc. | $18.42 | 1 |
| Kite Pharma, Inc. | $16.87 | 1 |
| Merck Sharp & Dohme Corporation | $15.19 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.08 | 1 |
| Lilly USA, LLC | $14.55 | 1 |
| Deciphera Pharmaceuticals Inc. | $13.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (47)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.